Prescient partners with global cancer heavyweight to develop new treatments
Prescient Therapeutics (ASX:PTX) has formed a cancer research partnership with the world-renowned Peter MacCallum Cancer Centre,...
Prescient Therapeutics (ASX:PTX) has formed a cancer research partnership with the world-renowned Peter MacCallum Cancer Centre,...
Special Report: Biotech company Prescient Therapeutics is advancing to next-stage trials for its personalised treatments...
Stockhead’s resident Health and Biotech expert Tim Boreham is coming to you live from the 2019...

This investor centre was built by Reach Markets
©2025 Reach Markets
To stay up to date with Prescient Therapeutics news and events, please register your details.